Literature DB >> 3821826

Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

I Madrazo, R Drucker-Colín, V Díaz, J Martínez-Mata, C Torres, J J Becerril.   

Abstract

Recent experimental studies and one clinical case have suggested that grafting tissue from the adrenal medulla into the brain may ameliorate the signs of Parkinson's disease. We describe the treatment of two young patients (35 and 39 years old) with intractable and incapacitating Parkinson's disease, in whom fragments of the adrenal medulla were autotransplanted to the right caudate nucleus. Clinical improvement was noted in both patients at 15 and 6 days (respectively) after implantation and has continued in both. Rigidity and akinesia had virtually disappeared in the first patient at 10 months after surgery, and his tremor was greatly reduced. A similar degree of improvement was present in the second patient at three months. We conclude that autografting of the adrenal medulla to the right caudate nucleus was associated with a marked improvement in the signs of Parkinson's disease in two patients, but our results are preliminary and further work is necessary to see whether this procedure will be applicable over the long term in other types of patients with Parkinson's disease.

Entities:  

Mesh:

Year:  1987        PMID: 3821826     DOI: 10.1056/NEJM198704023161402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  63 in total

1.  Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Authors:  B Lach; D Grimes; B Benoit; A Minkiewicz-Janda
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

Review 3.  Cell implantation in Parkinson's disease.

Authors:  A Williams
Journal:  BMJ       Date:  1990-08-11

4.  Chromaffin progenitor cells from the adrenal medulla.

Authors:  Monika Ehrhart-Bornstein; Vladimir Vukicevic; Kuei-Fang Chung; Mushfika Ahmad; Stefan R Bornstein
Journal:  Cell Mol Neurobiol       Date:  2010-11-16       Impact factor: 5.046

5.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 6.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 7.  The history and future of deep brain stimulation.

Authors:  Jason M Schwalb; Clement Hamani
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity.

Authors:  Joseph Yanai; Yael Brick-Turin; Sharon Dotan; Rachel Langford; Adi Pinkas; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-02-13       Impact factor: 3.763

9.  Cell implantation in Parkinson's disease.

Authors:  I Madrazo; M Aguilera; R Franco-Bourland
Journal:  BMJ       Date:  1990-10-13

10.  Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus.

Authors:  I Date; K Kawamura; H Nakashima
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.